15614 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices 

TABLE 1—INFORMATION ON PARTICIPATION IN THE MEETING AND ON SUBMITTING COMMENTS TO THE DOCKET— 

Continued 

Dates Electronic addresses Addresses Other information 

Submit electronic 

or written comments.

Submit comments by May 

26, 2015.

Federal eRulemaking Portal: 

http://www.regulations.gov. Follow the instructions for submitting comments.

Mail/Hand delivery/Courier (for 

paper submissions): Division of 

Dockets Management (HFA– 

305), Food and Drug Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852.

Identify your comments with the 

docket number listed in brackets in the heading of this document. We encourage you to 

submit electronic comments by 

using the Federal eRulemaking 

Portal. 

1You may also register via email, mail, or fax. Please include your name, title, firm name, address, and phone and fax numbers in your registration information and send to: Courtney Treece, Planning Professionals Ltd., 1210 West McDermott Dr., suite 111, Allen, TX 75013, 704– 

258–4983, FAX: 469–854–6992, email: ctreece@planningprofessionals.com. 

IV. Comments, Transcripts, and 

Recorded Video 

Regardless of attendance at the public 

meeting, interested persons may submit 

to FDA’s Division of Dockets 

Management (see Addresses in table 1 of 

this document) either electronic or 

written comments on FSMA 

implementation issues. You only need 

to send one set of comments. Identify 

the comments with the docket number 

listed in brackets in the heading of this 

document. However, we will not use 

any information or data submitted 

during the public meeting or through 

the docket to inform any FSMA 

rulemakings where the comment 

periods have closed. 

With respect to transcripts, please be 

advised that as soon as a transcript is 

available it will be accessible at http:// 

www.regulations.gov and at FDA’s 

FSMA Web site at http://www.fda.gov/ 

FSMA. You may also view the transcript 

at the Division of Dockets Management 

(HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, rm. 

1061, Rockville, MD 20852. A transcript 

will also be available in either hardcopy 

or on CD–ROM, after submission of a 

Freedom of Information request. Send 

written requests to the Division of 

Freedom of Information (ELEM–1029), 

12420 Parklawn Dr., Element Bldg., 

Rockville, MD 20857. 

Additionally, we will be video 

recording the public meeting. Once the 

recorded video is available, it will be 

accessible at FDA’s FSMA Web site at 

http://www.fda.gov/FSMA. 

Dated: March 18, 2015. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2015–06656 Filed 3–23–15; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Interagency Committee on Smoking 

and Health: Notice of Charter Renewal 

This gives notice under the Federal 

Advisory Committee Act (Pub. L. 92– 

463) of October 6, 1972, that the 

Interagency Committee on Smoking and 

Health, Department of Health and 

Human Services, has been renewed for 

a 2-year period through March 20, 2017. 

For information, contact Simon 

McNabb, Designated Federal Officer, 

Interagency Committee on Smoking and 

Health, Centers for Disease Control and 

Prevention, Department of Health and 

Human Services, Patriot’s Plaza, 395 E 

Street SW., M/S P06, Washington, DC 

20201, telephone 202/245–0550 or fax 

202/245–0599, Email: BOL1@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2015–06649 Filed 3–23–15; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Toxic Substances and 

Disease Registry 

[60Day–15–15TG; Docket No. CDC–2015– 

0009] 

Proposed Data Collection Submitted 

for Public Comment and 

Recommendations 

AGENCY: Agency for Toxic Substances 

and Disease Registry (ATSDR), Centers 

for Disease Control and Prevention 

(CDC). 

ACTION: Notice with comment period. 

SUMMARY: The Agency for Toxic 

Substances and Disease Registry 

(ATSDR), as part of its continuing 

efforts to reduce public burden and 

maximize the utility of government 

information, invites the general public 

and other Federal agencies to take this 

opportunity to comment on proposed 

and/or continuing information 

collections, as required by the 

Paperwork Reduction Act of 1995. This 

notice invites comment on Promotion of 

the National Amyotrophic Lateral 

Sclerosis (ALS) Registry to Non-referral 

Centers. 

DATES: Written comments must be 

received on or before May 26, 2015. 

ADDRESSES: You may submit comments, 

identified by Docket No. CDC–2015– 

0009 by any of the following methods: 

• Federal eRulemaking Portal: 

Regulation.gov. Follow the instructions 

for submitting comments. 

• Mail: Leroy A. Richardson, 

Information Collection Review Office, 

Centers for Disease Control and 

Prevention, 1600 Clifton Road NE., MS– 

D74, Atlanta, Georgia 30329. 

Instructions: All submissions received 

must include the agency name and 

Docket Number. All relevant comments 

received will be posted without change 

to Regulations.gov, including any 

personal information provided. For 

access to the docket to read background 

mstockstill on DSK4VPTVN1PROD with NOTICES